HIPREX Drug Patent Profile
✉ Email this page to a colleague
When do Hiprex patents expire, and what generic alternatives are available?
Hiprex is a drug marketed by Ss Pharma and is included in one NDA.
The generic ingredient in HIPREX is methenamine hippurate. There are ten drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methenamine hippurate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hiprex
A generic version of HIPREX was approved as methenamine hippurate by AUROBINDO PHARMA LTD on July 5th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HIPREX?
- What are the global sales for HIPREX?
- What is Average Wholesale Price for HIPREX?
Summary for HIPREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Clinical Trials: | 2 |
| Patent Applications: | 1,945 |
| Drug Prices: | Drug price information for HIPREX |
| What excipients (inactive ingredients) are in HIPREX? | HIPREX excipients list |
| DailyMed Link: | HIPREX at DailyMed |
Recent Clinical Trials for HIPREX
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Texas Southwestern Medical Center | Phase 4 |
| University of Pennsylvania | N/A |
US Patents and Regulatory Information for HIPREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ss Pharma | HIPREX | methenamine hippurate | TABLET;ORAL | 017681-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
